Cellectis - ADR

NASDAQ:CLLS   4:00:00 PM EDT
3.08
-0.08 (-2.53%)
7:35:27 PM EDT: $3.15 +0.07 (+2.27%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)222.05M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$9.55 Million
Adjusted EPS-$0.23
See more estimates
10-Day MA$2.94
50-Day MA$2.56
200-Day MA$1.78
See more pivots

Cellectis - ADR Stock, NASDAQ:CLLS

8, rue de la Croix Jarry, Paris, Ile-de-France 75013
France
Phone: +33.1.81.69.16.00
Number of Employees: 222
http://www.cellectis.com

Description

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andr�© Choulika on February 20, 1999 and is headquartered in Paris, France.